Rexahn Pharmaceuticals, Inc. (REXN)

[drkazmd65]

Am still in the early stages of figuring RNN out myself Dionna - seems like it's in a relatively good place for a clinical-stage (Phase I or Phase II) bio-pharma.

Only started watching RNN myself during the last few weeks because of some the recent reviews from others who's viewpoints I think are good. Haven't bought in here yet - am in the 'thinking about it' stage.

They have no revenues yet,.... but that's nothing unusual for a company at this stage.

They are probably going to have to do a capital raise in the near-future as the cash burn is high, cash reserves are not huge, and because going into a Phase III testing is only going to push that cash burn to a higher level. So there is continued danger of near-term dilution for shareholders even though in the longer run it is likely to still net the patient a gain.

The reviews do appear to be generally good. But fact remains - they are a good distance from being a revenue generator, so I think that the market reflects that reality.

I suspect that they'll get a boost as the current clinical trials finish out, but unless somebody with deep pockets is willing to bankroll Phase III - shareprices will stay low for a while.